NASDAQ:LFMD

LifeMD (LFMD) Stock Forecast, Price & News

$5.89

+0.39 (+7.09%)

(As of 09/28/2023 ET)

Compare

Today's Range: $5.34
▼
$5.92
50-Day Range: $3.49
▼
$5.50
52-Week Range: $1.14
▼
$5.92

Volume: 814,575 shs
Average Volume: 253,211 shs
Market Capitalization: $212.22 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $7.50

LifeMD MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 27.3% Upside
$7.50 Price Target
Short Interest: Bearish
7.83% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.83
Based on 4 Articles This Week
Insider Trading: Acquiring Shares
$350,618 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($0.65) to ($0.23) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.05 out of 5 stars

Medical Sector

566th out of 969 stocks

Offices & Clinics Of Medical Doctors Industry

3rd out of 6 stocks

3.5

Analyst's Opinion

Consensus Rating
LifeMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $7.50, LifeMD has a forecasted upside of 27.3% from its current price of $5.89.
Amount of Analyst Coverage
LifeMD has only been the subject of 2 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
7.83% of the float of LifeMD has been sold short.
Short Interest Ratio / Days to Cover
LifeMD has a short interest ratio ("days to cover") of 4.6.
Change versus previous month
Short interest in LifeMD has recently increased by 4.93%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
LifeMD does not currently pay a dividend.
Dividend Growth
LifeMD does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for LFMD.

3.2

News and Social Media Coverage

News Sentiment
LifeMD has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for LifeMD this week, compared to 0 articles on an average week.
Search Interest
Only 4 people have searched for LFMD on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
MarketBeat Follows
9 people have added LifeMD to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LifeMD insiders have bought more of their company's stock than they have sold. Specifically, they have bought $350,618.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
18.89% of the stock of LifeMD is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 17.57% of the stock of LifeMD is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for LifeMD are expected to grow in the coming year, from ($0.65) to ($0.23) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of LifeMD is -5.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of LifeMD is -5.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About LifeMD (NASDAQ:LFMD) Stock

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including urgent and primary care, men's and women's health, and dermatology, chronic care management, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and food and drug administration approved medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and NavaMD, a female-oriented and tele-dermatology brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. The company sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

LFMD Price History

30 days | 90 days | 365 days | Advanced Chart

LFMD Stock News Headlines

September 27, 2023 | finance.yahoo.com

LifeMD to Participate in Two Investor Conferences in October

September 26, 2023 | realmoney.thestreet.com

An Update on My Top Small-Cap Pick and What It Means for the Overall Market

September 28, 2023 | Micro-Cap Stock Trader (Ad)

U.S. drive to onshore battery supply chains could create big winners in lithium

Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons

September 25, 2023 | realmoney.thestreet.com

As the Market Struggles to Bounce, I'm Watching These 7 Stocks

September 21, 2023 | finance.yahoo.com

LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy

September 15, 2023 | realmoney.thestreet.com

My Top Small-Cap Pick for a Strong Year-End Run

September 3, 2023 | finance.yahoo.com

Bertrand Velge Bought 12% More Shares In LifeMD

August 30, 2023 | finance.yahoo.com

LifeMD to Participate in Two Investor Conferences in September

September 28, 2023 | Micro-Cap Stock Trader (Ad)

U.S. drive to onshore battery supply chains could create big winners in lithium

Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons

August 13, 2023 | realmoney.thestreet.com

I've Got a Play for LifeMD as It Gets Its Life Together

August 10, 2023 | realmoney.thestreet.com

Is the July CPI Report Really Good News?

August 8, 2023 | markets.businessinsider.com

B.Riley Financial Sticks to Its Buy Rating for LifeMD (LFMD)

August 2, 2023 | finance.yahoo.com

LifeMD to Present at Sidoti’s Micro-Cap Virtual Conference

July 27, 2023 | finance.yahoo.com

LifeMD to Report Second Quarter 2023 Financial Results on August 9

July 21, 2023 | markets.businessinsider.com

LifeMD Shares Undervalued: Analyst Initiates With Outperform Rating

July 10, 2023 | markets.businessinsider.com

B.Riley Financial Reaffirms Their Buy Rating on LifeMD (LFMD)

June 27, 2023 | finance.yahoo.com

LifeMD Elevates Successful GLP-1 Weight Management Program with Proprietary Platform Enhancements

June 16, 2023 | realmoney.thestreet.com

3 Potential Turnarounds in Small-Cap Stocks to Watch

May 23, 2023 | finance.yahoo.com

LifeMD, Inc. to Present at the June 1st Virtual Investor Summit

May 12, 2023 | marketwatch.com

LifeMD, Inc. Reports First Quarter 2023 Results; Record Revenues and Adjusted EBITDA

May 11, 2023 | markets.businessinsider.com

LifeMD earnings: here's what Wall Street expects

May 3, 2023 | finance.yahoo.com

LifeMD, Inc. to Announce First Quarter 2023 Financial Results on May 12, 2023

April 24, 2023 | finance.yahoo.com

LifeMD Launches New Features and Membership Plans to Improve Patient Experience and Broaden Access to Healthcare

March 22, 2023 | finance.yahoo.com

LifeMD, Inc. Announces Closing of New $40 Million Credit Facility

March 7, 2023 | finance.yahoo.com

LifeMD, Inc. to Announce Fourth Quarter, Full Year 2022 Financial Results on March 22, 2023

February 10, 2023 | finance.yahoo.com

LifeMD Appoints Dr. Joan LaRovere to its Board of Directors

January 4, 2023 | finance.yahoo.com

LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company’s Rapid Expansion into Virtual Primary Care

See More Headlines

Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

LFMD Company Calendar

Last Earnings: 8/09/2023
Today: 9/28/2023
Next Earnings (Estimated): 11/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Offices & clinics of medical doctors
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:LFMD
CUSIP: N/A
CIK: 948320
Web: www.lifemd.com
Phone: (866) 351-5907
Fax: N/A
Employees: 199
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $7.50
High Stock Price Forecast: $9.00
Low Stock Price Forecast: $7.00
Forecasted Upside/Downside: +27.3%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-45,540,000.00
Net Margins: -23.30%
Pretax Margin: -21.57%
Return on Equity: -7,255.81%
Return on Assets: -71.19%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.64
Quick Ratio: 0.52

Sales & Book Value

Annual Sales: $119.03 million
Price / Sales: 1.78
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.38) per share
Price / Book: -15.50

Miscellaneous

Outstanding Shares: 36,030,000
Free Float: 29,226,000
Market Cap: $212.22 million
Optionable: Optionable
Beta: 1.69

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Justin Schreiber (Age 40)
Chairman & CEO
Comp: $255k

Mr. Marc Benathen (Age 42)
Chief Financial Officer
Comp: $378.75k

Mr. Eric H. Yecies (Age 45)
Chief Compliance Officer, Gen. Counsel & Sec.
Comp: $332k

Mr. Brad Michael Roberts (Age 42)
Chief Operating Officer

Ms. Maria E. Stan CPA (Age 48)
Controller & Principal Accounting Officer

Mr. Dennis Wijnker (Age 47)
Chief Technology Officer

Ms. Jessica Friedeman (Age 39)
Chief Marketing Officer

Mr. Stefan Galluppi (Age 36)
Chief Innovation Officer

Mr. Nicholas P. Alvarez (Age 41)
Chief Acquisition Officer & Head of Customer Acquisition

Mr. Varun Pathak
Chief Software Engineer & Co-Founder of PDF Simpli

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

LFMD Stock - Frequently Asked Questions

Should I buy or sell LifeMD stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeMD in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LFMD shares.
View LFMD analyst ratings or view top-rated stocks.
What is LifeMD's stock price forecast for 2023?: 3 Wall Street analysts have issued twelve-month price objectives for LifeMD's stock. Their LFMD share price forecasts range from $7.00 to $9.00. On average, they predict the company's share price to reach $7.50 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.
View analysts price targets for LFMD or view top-rated stocks among Wall Street analysts.
How have LFMD shares performed in 2023?: LifeMD's stock was trading at $1.94 on January 1st, 2023. Since then, LFMD stock has increased by 203.6% and is now trading at $5.89.
View the best growth stocks for 2023 here.
When is LifeMD's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our LFMD earnings forecast.
How were LifeMD's earnings last quarter?: LifeMD, Inc. (NASDAQ:LFMD) announced its quarterly earnings data on Wednesday, August, 9th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.14. The business earned $35.95 million during the quarter, compared to analyst estimates of $35.29 million. LifeMD had a negative net margin of 23.30% and a negative trailing twelve-month return on equity of 7,255.81%.
What guidance has LifeMD issued on next quarter's earnings?: LifeMD updated its third quarter 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $37.50 million-$38.50 million, compared to the consensus revenue estimate of $37.31 million.

What is LifeMD's stock symbol?: LifeMD trades on the NASDAQ under the ticker symbol "LFMD."
Who are LifeMD's major shareholders?: LifeMD's stock is owned by many different institutional and retail investors. Top institutional shareholders include Royce & Associates LP (3.15%), B. Riley Financial Inc. (1.43%), BlackRock Inc. (1.19%), Granahan Investment Management LLC (0.85%), Geode Capital Management LLC (0.70%) and Marshall Wace LLP (0.36%). Insiders that own company stock include Bertrand Velge, Brad Michael Roberts, Corey Deutsch, Eric Harold Yecies, Happy David Walters, Joseph Ditrolio, Justin Schreiber, Marc David Benathen, Naveen Bhatia, Nicholas P Alvarez and Stefan Galluppi.
View institutional ownership trends.
How do I buy shares of LifeMD?: Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is LifeMD's stock price today?: One share of LFMD stock can currently be purchased for approximately $5.89.
How much money does LifeMD make?: LifeMD (NASDAQ:LFMD) has a market capitalization of $212.22 million and generates $119.03 million in revenue each year. The company earns $-45,540,000.00 in net income (profit) each year or ($1.04) on an earnings per share basis.
How many employees does LifeMD have?: The company employs 199 workers across the globe.
How can I contact LifeMD?: LifeMD's mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The official website for the company is www.lifemd.com. The company can be reached via phone at (866) 351-5907 or via email at cdeutsch@lifemd.com.

This page (NASDAQ:LFMD) was last updated on 9/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial